| 73 |
Prognostic value of echocardiographic indices in risk stratification of intermediate-risk pulmonary embolism |
Department of Chest Diseases |
2023 |
| 74 |
Behavioral, biochemical and histopathological toxic profiles induced by sub-chronic cannabimimetic WIN55, 212–2 administration in mice |
Department of Forensic Medicine and Clinical Toxicology |
2023 |
| 75 |
Punicalagin’s protective effects on Parkinson’s progression in socially isolated and socialized rats: insights into multifaceted pathway |
Department of Pharmacology |
2023 |
| 76 |
A meta analysis on the utility of Anakinra in severe COVID-19 disease |
Department of Chest Diseases |
2023 |
| 77 |
Continuous thoracic epidural versus continuous paravertebral analgesia in patients undergoing open renal surgery: Evaluation of pulmonary function; randomized double-blinded … |
Department of Anesthesia and Intensive Care |
2023 |
| 78 |
Standards for structured reporting of dual-energy X-ray absorptiometry scans: best practice recommendations by the Pan Arab Osteoporosis Society |
Department of Rheumatology ,Rehabilitation & physical medicine |
2023 |
| 79 |
Detection of Pattern of Some Unusual Signs and Symptoms of Multiple Sclerosis |
Department of Neurology and Psychiatry |
2023 |
| 80 |
Prognostic value of echocardiographic indices in risk stratification of intermediate‑risk pulmonary embolism |
Department of Chest Diseases |
2023 |
| 81 |
ZBTB16::RARA variant acute promyelocytic leukemia (vAPL) treated with gemtuzumab ozogamicin (GO) with unique pathology and genetic findings |
Department of Clinical Pathology |
2023 |
